KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Change in Cash (2018 - 2025)

Historic Change in Cash for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$3.3 million.

  • ClearPoint Neuro's Change in Cash rose 7054.65% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.8 million, marking a year-over-year increase of 70772.84%. This contributed to the annual value of -$3.0 million for FY2024, which is 3215.64% up from last year.
  • Latest data reveals that ClearPoint Neuro reported Change in Cash of -$3.3 million as of Q3 2025, which was up 7054.65% from $29.3 million recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Change in Cash registered a high of $44.8 million during Q1 2021, and its lowest value of -$26.1 million during Q2 2022.
  • Over the past 5 years, ClearPoint Neuro's median Change in Cash value was -$3.3 million (recorded in 2025), while the average stood at $963263.2.
  • In the last 5 years, ClearPoint Neuro's Change in Cash crashed by 68386.32% in 2022 and then soared by 126961.72% in 2025.
  • Quarter analysis of 5 years shows ClearPoint Neuro's Change in Cash stood at -$3.5 million in 2021, then skyrocketed by 351.36% to $8.9 million in 2022, then plummeted by 113.5% to -$1.2 million in 2023, then decreased by 22.21% to -$1.5 million in 2024, then crashed by 126.0% to -$3.3 million in 2025.
  • Its Change in Cash stands at -$3.3 million for Q3 2025, versus $29.3 million for Q2 2025 and -$7.7 million for Q1 2025.